Pharma Focus Asia

Indiana University Invests US$250 million to Open Life Sciences Campus in Indianapolis, USA

Introduction:

Indiana University plans to invest US$250 million to open a new campus to advance scientific discoveries aimed at curing and treating diseases and improving human health. 

Features:

Among the US$250 million investment, the facility invests US$30 million in constructing and renovating an additional 48,000 square feet within the new 11-storey, 326,000-square-foot medical education and research building at the IU School of Medicine to expand research infrastructure and educational resources.

This aims to provide state-of-the-art research laboratories, enhanced teaching spaces, and additional support areas.

Another investment of US$60 million will bolster STEM research and laboratory space, fuelling the expansion and renovation of interdisciplinary research facilities.

The investment of US$47.4 million over the next five years will support the recruitment of new faculty members in fields related to biosciences, biotechnology, and human health.

Allocating US$46.1 million toward faculty startup costs at IU Bloomington aims to catalyse innovative and interdisciplinary health science research. This investment will foster academic-industry collaborations, amplify federal grants, and expand contracts.

Expected to be completed by 2025, this development enables to advancing medical education and research capabilities, fostering innovation, and accommodating the evolving needs of students, faculty, and researchers.

Specifications:

Name     Indiana University
Type       New Construction
Budget   US$250 million
Year        2025
 

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference